Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andras Kozma"'
Autor:
Sarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, Emma Adam, Andras Bors, Judit Csomor, Laszlo Gopcsa, Magdalena Koszarska, Andras Kozma, Nora Lovas, Sandor Lueff, Zoltan Matrai, Nora Meggyesi, Janos Sinko, Andrea Sipos, Andrea Varkonyi, Sandor Fekete, Attila Tordai, Tamas Masszi
Publikováno v:
Haematologica, Vol 96, Iss 11 (2011)
Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has bee
Externí odkaz:
https://doaj.org/article/ac88012fc4f3488ab632138d40c784fc
Autor:
Christoph Odenbreit, Andras Kozma
Publikováno v:
ce/papers. 3:283-288
Autor:
Andras Kozma, Christoph Odenbreit
Publikováno v:
Life-Cycle Civil Engineering: Innovation, Theory and Practice ISBN: 9780429343292
info:eu-repo/grantAgreement/EC/H2020/710040
info:eu-repo/grantAgreement/EC/H2020/710040
In the face of climate change and the depletion of finite resources, sustainability is becoming increasingly important recently. This is especially true in the construction industry that is responsible for the 11% of global carbon dioxide emissions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6323e7f0abacc66946b29a3739919f9b
https://doi.org/10.1201/9780429343292-66
https://doi.org/10.1201/9780429343292-66
Autor:
Andrea Ceglédi, Zoltán Csukly, Mónika Fekete, András Kozma, Zsuzsanna Szemlaky, Hajnalka Andrikovics, Gábor Mikala
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Introduction: The selective Bcl-2 inhibitor venetoclax has shown promising therapeutic potential in multiple myeloma, particularly in cases associated with t(11;14) IGH::CCND1 translocation. However, the efficacy of venetoclax in myeloma patients wit
Externí odkaz:
https://doaj.org/article/f1942aab14334e64bc29fb8dba190576
Autor:
Christoph Odenbreit, Andras Kozma
Publikováno v:
IOP Conference Series: Earth and Environmental Science. 225:012028
Autor:
András Bors, András Kozma, Ágnes Tomán, Zoltán Őrfi, Nóra Kondor, Szabolcs Tasnády, István Vályi-Nagy, Péter Reményi, Gábor Mikala, Hajnalka Andrikovics
Publikováno v:
Cancers, Vol 16, Iss 2, p 283 (2024)
Multiple myeloma (MM) is the second most common hematological malignancy. Approximately 15% of MM patients are affected by the t(4;14) translocation resulting in the IGH::NSD2 fusion transcript. Breakage occurs in three major breakpoint regions withi
Externí odkaz:
https://doaj.org/article/76fe38e575044e6ba81cfe0a0961e24b
Autor:
Petra Kövy, Zoltán Őrfi, András Bors, András Kozma, László Gopcsa, János Dolgos, Nóra Lovas, József Harasztdombi, Viktor Lakatos, Ágnes Király, Gábor Mikala, István Vályi-Nagy, Péter Reményi, Hajnalka Andrikovics
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253386 (2021)
Monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML) plays an important role in predicting relapse and outcome. The applicability of the leukemia-initiating nucleophosmin1 (NPM1) gene mutations in MRD detection is well-establi
Externí odkaz:
https://doaj.org/article/a29c4b9b870e4ce6a27101d22d6b7a81
Autor:
Julia Tamaska, Emma Adam, Andras Kozma, Laszlo Gopcsa, Hajnalka Andrikovics, Attila Tordai, Gabriella Halm, Laszlo Bereczki, Eniko Bagdi, Laszlo Krenacs
Publikováno v:
Virchows Archiv: European Journal of Pathology; Oct2006, Vol. 449 Issue 4, p479-483, 5p